Court allows Aurobindo Pharma head Sarath P Reddy to turn ED's approver in alleged excise policy case

Published On 2023-06-02 09:00 GMT   |   Update On 2023-06-02 09:01 GMT
Advertisement

New Delhi: The Rouse Avenue Court on Thursday allowed the Hyderabad-based businessman P Sarath Reddy to turn approver for ED in an alleged excise policy case.

The Special Judge MK Nagpal on Thursday allowed Reddy to turn approver in the case while also granting him pardon.

Sarath P Reddy was recently granted regular bail by Delhi High Court on medical grounds. Reddy is the head of a Hederabad-based Aurobindo Pharma company and is engaged in liquor business, said the ED in court earlier.

Advertisement

Read also: Aurobindo Pharma Director gets bail in Delhi Excise Policy Case

While arguing against Sarath Reddy, ED earlier submitted that it is amply evident that, he had actively planned and conspired with various business owners and politicians and indulged in unfair market practices to gain undue advantage in the Delhi Excise Policy, 2021-22. Applicant led a nexus controlling a considerable market share through cartelization in clear contravention of objectives of Delhi Excise Policy.

Earlier, Delhi-based businessman Dinesh Arora turned approbation in CBI case. While moving an application Arora said, ” I am ready to make true disclosure voluntarily about the case and want to be an approver in the case”

Read also: Court sends Aurobindo Pharma Director Sarath Chandra Reddy to judicial custody till 5 December in Delhi Excise Policy case




Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News